摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N'-bis(adamantyl)imidazol-2-ylidene | 133947-56-5

中文名称
——
中文别名
——
英文名称
N,N'-bis(adamantyl)imidazol-2-ylidene
英文别名
IAd;1,3-bis(1-adamantyl)imidazol-2-ylidene;IAda;1,3-bis(1-adamantyl)-2H-imidazole
N,N'-bis(adamantyl)imidazol-2-ylidene化学式
CAS
133947-56-5
化学式
C23H34N2
mdl
——
分子量
338.536
InChiKey
PLONOWACPBEYFD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    25
  • 可旋转键数:
    2
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    6.5
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • N-(PHOSPHINOALKYL)-N-(THIOALKYL)AMINE DERIVATIVE, METHOD FOR PRODUCING SAME, AND METAL COMPLEX THEREOF
    申请人:TAKASAGO INTERNATIONAL CORPORATION
    公开号:US20170233418A1
    公开(公告)日:2017-08-17
    The purpose of the present invention is to provide: a ligand that is useful in a catalytic organic synthetic reaction; a method for producing said ligand; and a metal complex that is useful as a catalyst in an organic synthetic reaction. The present invention provides a compound represented by general formula (1 A ), a method for producing said compound, and a metal complex including said compound as a ligand. (In the formula, H, N, P, S, L, R 1 , R 2 , R 3 , Q 1 , and Q 2 have the meaning as defined in the Description.)
    本发明的目的是提供:在催化有机合成反应中有用的配体;制备所述配体的方法;以及在有机合成反应中作为催化剂有用的属配合物。本发明提供了由通式(1A)表示的化合物,制备所述化合物的方法,以及包括所述化合物作为配体属配合物。(在该式中,H、N、P、S、L、R1、R2、R3、Q1和Q2的含义如描述中所定义。)
  • BIODEGRADABLE ORGANIC RADICAL-FUNCTIONALIZED POLYCARBONATES FOR MEDICAL APPLICATIONS
    申请人:International Business Machines Corporation
    公开号:US20160220705A1
    公开(公告)日:2016-08-04
    Paramagnetic, amphiphilic, biocompatible polymers were prepared comprising a carbonate repeat unit bearing a paramagnetic organic radical, more specifically a nitroxyl radical. The radical polymers can be produced in one step from a precursor polymer bearing an active ester side chain by treating the precursor polymer with a radical-bearing nucleophile. The precursor polymer can be prepared by organocatalyzed catalyzed ring opening polymerization (ROP) of a cyclic carbonate monomer bearing an active ester side chain. The radical polymers can be non-toxic and partially biodegradable. The radical polymers have utility as contrast enhancing agents in a medical imaging application and/or as therapeutic agents for treating a medical condition. The radical polymers can also serve as carriers for therapeutic agents (e.g., drugs) and/or medical image enhancing agents (e.g., NIRF dyes).
    具有顺磁性、两性亲疏性、生物相容性的聚合物已经制备好,其中包含一个带有顺磁性有机自由基的碳酸酯重复单元,更具体地说是一个亚硝基自由基。这种自由基聚合物可以通过将带有活性酯侧链的前体聚合物与带有自由基的亲核试剂处理而一步制备而成。前体聚合物可以通过有机催化的环氧化聚合(ROP)来制备,该环氧化单体带有活性酯侧链。这种自由基聚合物可能是无毒且部分可生物降解的。这种自由基聚合物在医学成像应用中可用作增强对比剂,和/或作为治疗医疗状况的治疗剂。这种自由基聚合物还可以作为治疗剂(例如药物)和/或医学图像增强剂(例如NIRF染料)的载体。
  • CYCLIC CARBONYL COMPOUNDS WITH PENDANT CARBONATE GROUPS, PREPARATIONS THEREOF, AND POLYMERS THEREFROM
    申请人:Fujiwara Masaki
    公开号:US20110269917A1
    公开(公告)日:2011-11-03
    A one pot method of preparing cyclic carbonyl compounds comprising an active pendant pentafluorophenyl carbonate group is disclosed. The cyclic carbonyl compounds can be polymerized by ring opening methods to form ROP polymers comprising repeat units comprising a side chain pentafluorophenyl carbonate group. Using a suitable nucleophile, the pendant pentafluorophenyl carbonate group can be selectively transformed into a variety of other functional groups before or after the ring opening polymerization.
    公开了一种制备含有活性吊挂五苯基碳酸酯基团的环状羰基化合物的一锅法。这些环状羰基化合物可以通过环开启方法聚合,形成包含侧链五苯基碳酸酯基团的ROP聚合物重复单元。使用适当的亲核试剂,可以在环开启聚合之前或之后,选择性地将吊挂的五苯基碳酸酯基团转化为各种其他功能基团。
  • HYDROSILYLATION IRON CATALYST
    申请人:KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
    公开号:US20170260216A1
    公开(公告)日:2017-09-14
    A hydrosilylation iron catalyst prepared from a two-electron ligand (L) and a mononuclear, binuclear, or trinuclear complex of iron indicated by formula (1), Fe having bonds with carbon atoms included in X and the total number of Fe-carbon bonds being 2-10. As a result of using iron, the hydrosilylation iron catalyst is advantageous from a cost perspective as well as being easily synthesized. Hydrosilylation reactions can be promoted under mild conditions by using this catalyst. Fe(X) a (1) (in the formula, each X independently indicates a C2-30 ligand that may include an unsaturated group excluding carbonyl groups (CO groups) and cyclopentadienyl groups, however at least one X includes an unsaturated group, a indicates an integer of 2-4 per Fe atom.)
    使用双电子配体(L)和由公式(1)表示的的单核、双核或三核配合物制备的硅化铁催化剂,其中Fe与X中包含的碳原子形成键,Fe-碳键的总数为2-10。由于使用硅化铁催化剂从成本角度来看具有优势,同时也易于合成。通过使用这种催化剂,可以在温和条件下促进化反应。在公式中,每个X独立地表示一个可能包括除羰基(CO基团)和环戊二烯基团以外的不饱和基团的C2-30配体,然而至少有一个X包括不饱和基团,a表示每个原子2-4的整数。)
  • ANTIMICROBIAL CATIONIC POLYCARBONATES
    申请人:INTERNATIONAL BUSINESS MACHINES CORPORATION
    公开号:US20140301967A1
    公开(公告)日:2014-10-09
    Antimicrobial cationic polymers having one or two cationic polycarbonate chains were prepared by organocatalyzed ring opening polymerization. One antimicrobial cationic polymer has a polymer chain consisting essentially of cationic carbonate repeat units linked to one or two end groups. The end groups can comprise a covalently bound form of biologically active compound such as cholesterol. Other antimicrobial cationic polymers have a random copolycarbonate chain comprising a minor mole fraction of hydrophobic repeat units bearing a covalently bound form of a vitamin E and/or vitamin D2. The cationic polymers exhibit high activity and selectivity against Gram-negative and Gram-positive microbes and fungi.
    具有一个或两个阳离子聚碳酸酯链的抗菌阳离子聚合物是通过有机催化的环氧开聚合制备的。其中一种抗菌阳离子聚合物具有基本由阳离子碳酸酯重复单元构成的聚合物链,与一个或两个末端基团相连。末端基团可以包括胆固醇生物活性化合物的共价结合形式。其他抗菌阳离子聚合物具有随机共聚碳酸酯链,其中含有少量疏重复单元,带有维生素E和/或维生素D2的共价结合形式。这些阳离子聚合物对革兰氏阴性和革兰氏阳性微生物和真菌表现出高活性和选择性。
查看更多

同类化合物

(4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] 香豆素-6-羧酸 顺式-3a,5,6,6a-四氢-3-(1-甲基乙基)-4H-环戊二烯并[d]异恶唑 锌离子载体IV 钐(III) 离子载体 II 苯,1-(2E)-2-丁烯-1-基-2-氟- 苯,(2,2-二氟乙烯基)- 聚二硫二噻唑烷 缩胆囊肽9 绕丹酸钠 盐(1:?)5'-尿苷酸,钠 甲酰乙内脲 甲巯咪唑 甲基羟甲基油基噁唑啉 甲基5-羟基-3,5-二甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-氰基-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基5-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基5-(羟基甲基)-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基4-甲基-5-氧代-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4,5-二氮杂螺[2.4]庚-5-烯-6-羧酸酯 甲基4,5-二氢-5-乙基-1H-吡唑-1-羧酸酯 甲基3-甲基-4,5-二氢-1,2-恶唑-4-羧酸酯 甲基(E)-3-[6-[1-羟基-1-(4-甲基苯基)-3-(1-吡咯烷基)丙基]-2-吡啶基]丙烯酰酸酯 甲基(5-氧代-4,5-二氢-1,2-恶唑-3-基)乙酸酯 环戊二烯并[d]咪唑-2,5(1H,3H)-二硫酮 环己羧酸,3-氨基-2-甲氧基-,甲基酯,(1S,2S,3S)- 溶剂黄93 溴化1-十六烷基-3-甲基咪唑 溴化1-十二烷基-2,3-二甲基咪唑 泰比培南酯中间体 泰比培南酯中间体 氨甲酸,[4,5-二氢-4-(碘甲基)-2-噻唑基]-,1,1-二甲基乙基酯(9CI) 氨基甲硫酸,[2-[[(2-羰基-1-咪唑烷基)硫代甲基]氨基]乙基]-,O-甲基酯 异噻唑,4,5-二氯-2,5-二氢-2-辛基- 希诺米啉 四氟硼酸二氢1,3-二(叔-丁基)-4,5--1H-咪唑正离子 四唑硝基紫 噻唑烷-2,4-二酮-2-缩氨基脲 噻唑丁炎酮 噻唑,4,5-二氢-4-(1-甲基乙基)-,(S)- 噁唑,4,5-二氢-4,4-二甲基-2-(5-甲基-2-呋喃基)- 噁唑,2-庚基-4,5-二氢- 咪唑烷基脲 吡嗪,2,3-二氢-5,6-二甲基-2-丙基- 叔-丁基3-羟基-1,4,6,7-四氢吡唑并[4,3-c]吡啶-5-羧酸酯 双吡唑啉酮